First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus
Titel:
First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus
Auteur:
Kapur, Anita O’Connor-Semmes, Robin Hussey, Elizabeth K Dobbins, Robert L Tao, Wenli Hompesch, Marcus Smith, Glenn A Polli, Joseph W James Jr, Charles D Mikoshiba, Imao Nunez, Derek J